Analysis of the effect of OATP1B3 genomic abnormality on hepatic ICG clearance

Analysis of the effect of OATP1B3 genomic abnormality on hepatic ICG clearance - Analysis of the effect of OATP1B3 genomic abnormality on hepatic ICG clearance

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032781

Enrollment

Registered

2018-06-01

Start date

2018-05-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hepatitis C

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic hepatitis C whose SLCO1B3 genotype was known.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
ICG clearance rate	—

Countries

Japan

Contacts

Public ContactTatehiro Kagawa

Tokai University School of Medicine Hepatology and Gastroenterology

kagawa@tokai.ac.jp0463-93-1121

Outcome results